B4 - Innovative drug delivery approaches to meet key challenges in global health

Sorry, Access to this content is only open to registered participants.
If you are not registered yet, click HERE for more information how to register for PSWC2020


Steven Kern (Bill and Melinda Gates Foundation) and Elise Laszlo (Université de Montréal, Canada)


This session will highlight how innovative drug delivery systems can be developed to solve challenges in global health that affect low and middle income countries.  There is a perception that solutions for challenges in low income settings require low cost to be useful.  But the challenges in delivering effective solutions to global health challenges encompasses both the unit cost for the solution and the effort to get the solution to the people who need them most.   This session will explore some novel drug delivery technologies that have the potential to improve the ability of therapeutic solutions to reach the people who need them most and thus provide a favorable cost to benefit ratio to motivate development.


Particles for Humanity:  developing encapsulated delivery system to help Global Health
Ana Jaklenec,  (Massachusetts Institute of Technology, USA)

Developing long lasting oral drug delivery systems for infectious disease
Jessica Ballinger (Lyndra Therapeutics,  USA)  

Novel drug delivery approaches to hormonal contraceptives
Dennis Lee (Bill & Melinda Gates Foundation, USA)

Panel discussion with the speakers and audience

Learning Objectives

  1. Understand the challenges that delivering global health solutions to low income countries entails.
  2. Explore the characteristics of novel drug delivery systems that make them suitable for use in low income settings.
  3. Understand the potential for dual-use markets to enable technology development that benefits low income settings.